Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

Cardizem Monovial approved for U.S. marketing

Sep. 23, 1997

Andrx's extended-release diltiazem receives tentative approval

Sep. 22, 1997

Dual IL-6/NO production inhibitors prepared at Takeda

Sep. 19, 1997

Dual ACE/NEP inhibitors described by Zambon

Sep. 18, 1997

KRN-4884 active in several preclinical models of hypertension

Sep. 18, 1997

Biovail licenses diltiazem for Scandinavian market

Sep. 17, 1997

A-127722.5, a selective, orally active ETA antagonist for restenosis

Sep. 17, 1997

Natrecor in CHF: phase III results

Sep. 16, 1997

Results with PLC Systems' TMR System reported

Sep. 16, 1997

Myocardial and cerebral vasodilating effects of BMS-180448 in animals

Sep. 15, 1997

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...